JP2024531188A5 - - Google Patents

Info

Publication number
JP2024531188A5
JP2024531188A5 JP2024508384A JP2024508384A JP2024531188A5 JP 2024531188 A5 JP2024531188 A5 JP 2024531188A5 JP 2024508384 A JP2024508384 A JP 2024508384A JP 2024508384 A JP2024508384 A JP 2024508384A JP 2024531188 A5 JP2024531188 A5 JP 2024531188A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
use according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024531188A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040115 external-priority patent/WO2023018904A1/en
Publication of JP2024531188A publication Critical patent/JP2024531188A/ja
Publication of JP2024531188A5 publication Critical patent/JP2024531188A5/ja
Pending legal-status Critical Current

Links

JP2024508384A 2021-08-11 2022-08-11 重水素化jak阻害剤による脱毛障害の治療 Pending JP2024531188A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163232107P 2021-08-11 2021-08-11
US63/232,107 2021-08-11
PCT/US2022/040115 WO2023018904A1 (en) 2021-08-11 2022-08-11 Treatment of hair loss disorders with deuterated jak inhibitors

Publications (2)

Publication Number Publication Date
JP2024531188A JP2024531188A (ja) 2024-08-29
JP2024531188A5 true JP2024531188A5 (https=) 2025-10-15

Family

ID=83151848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508384A Pending JP2024531188A (ja) 2021-08-11 2022-08-11 重水素化jak阻害剤による脱毛障害の治療

Country Status (7)

Country Link
US (2) US12285432B2 (https=)
EP (1) EP4384175A1 (https=)
JP (1) JP2024531188A (https=)
CN (1) CN118159272A (https=)
AU (1) AU2022328272A1 (https=)
CA (1) CA3228505A1 (https=)
WO (1) WO2023018904A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021372512A1 (en) * 2020-10-28 2023-06-22 Sun Pharmaceutical Industries, Inc. Regimens for the treatment of hair loss disorders with deuterated jak inhibitors
CA3228505A1 (en) 2021-08-11 2023-02-16 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
US12364699B2 (en) 2023-10-10 2025-07-22 Sun Pharmaceuticals Industries, Inc. Method of treating hair loss disorders
US20260027120A1 (en) * 2024-07-25 2026-01-29 Sun Pharmaceutical Industries, Inc. Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925962D0 (en) 1999-11-02 1999-12-29 Novartis Ag Organic compounds
CN1255185C (zh) 2001-05-03 2006-05-10 弗·哈夫曼-拉罗切有限公司 无定形甲磺酸奈非那韦的药物剂型
MX2007003731A (es) 2004-09-29 2007-08-14 Johnson & Johnson Formas de dosis farmaceuticas de compuestos similares a rapamicina amorfos estables.
US20070202077A1 (en) * 2005-12-02 2007-08-30 Brodsky Robert A Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders
SG10202003901UA (en) 2005-12-13 2020-05-28 Incyte Holdings Corp Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
CL2008001709A1 (es) 2007-06-13 2008-11-03 Incyte Corp Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
TWI720517B (zh) 2009-01-15 2021-03-01 美商英塞特公司 製造jak抑制劑之方法及相關中間化合物
US9198911B2 (en) 2010-11-02 2015-12-01 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
WO2012061537A2 (en) 2010-11-02 2012-05-10 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
DK2830662T3 (da) 2012-03-29 2019-01-02 Univ Columbia Fremgangsmåder til behandlng af hårtabsforstyrrelser
HRP20250965T1 (hr) * 2012-06-15 2025-10-10 Sun Pharmaceutical Industries, Inc. Deuterirani derivati ruksolitiniba
PH12020551186B1 (en) 2012-11-15 2024-03-20 Incyte Holdings Corp Sustained-release dosage forms of ruxolitinib
KR20160117596A (ko) 2014-02-07 2016-10-10 오스펙스 파마슈티칼스, 인코포레이티드 신규 제약 제제
ES2988629T3 (es) * 2016-05-04 2024-11-21 Sun Pharmaceutical Ind Inc Tratamiento de trastornos de pérdida de cabello con inhibidores de JAK deuterados
AU2020219797B2 (en) 2019-02-06 2025-10-16 Sun Pharmaceutical Industries, Inc. Process for preparing enantiomerically enriched jak inhibitors
CA3228505A1 (en) 2021-08-11 2023-02-16 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors

Similar Documents

Publication Publication Date Title
JP2024531188A5 (https=)
JP2022546471A5 (https=)
CN109890366B (zh) 治疗心血管疾病的组合药物及其制备和使用方法
JP2018510178A5 (https=)
JP2009514874A5 (https=)
EA020193B1 (ru) Комбинации, включающие метотрексат и ингибиторы дигидрооротатдегидрогеназы (dhodh)
JP2019516684A5 (https=)
WO2022218958A1 (en) Combination comprising everolimus and amcenestrant
JP2024507810A5 (https=)
JP2023553253A5 (https=)
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
EA028060B1 (ru) Комбинированная терапия бокового амиотрофического склероза
JP4786127B2 (ja) 色素沈着改善治療薬
JP2023548429A5 (https=)
JP2016505050A5 (https=)
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
JP2019509309A5 (https=)
JP2022177119A5 (https=)
MD4879C1 (ro) Utilizare a derivatului bisamidic al acidului malonic pentru tratarea bolilor alergice şi altor boli umane şi animaliere
JP2021530568A5 (https=)
JP2021091608A5 (https=)
CN118252833A (zh) Vofopitant用于治疗肺纤维化的用途
CN115942934A (zh) 卟啉症的预防或治疗剂
JP6420923B1 (ja) 医薬
CA2684938A1 (en) Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions